The validity of the atropine test.
In order to evaluate the clinical validity of the so-called "atropine test", it has been performed in 83 women in their 35th to 43rd week of pregnancy. A statistical evaluation of the data has shown a serious limitation of both diagnostic and prognostic possibilities of the test; this can be attributed to the great variability of maternal environments.
D001285:Atropine / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D005260:Female; D005316:Fetal Distress / Q000175:diagnosis*; D005318:Fetal Heart / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D011247:Pregnancy; D011379:Prognosis; D014427:Twins
D001285:Atropine